Centene Swings to $1.1 Billion Q2 Profit as Medical Costs Stabilize and ACA Business Rebounds
核心洞察
Centene (搜索) reported net income of $1.09 billion in Q2 2026, a dramatic turnaround from a $253 million loss in the same period last year.
The insurer's consolidated health benefits ratio improved to 89.6% from 93% year over year, signaling better control over medical costs.
ACA marketplace membership fell by nearly 2.4 million enrollees, but the remaining pool is significantly more profitable with a commercial MLR of 79.2%.
Health insurer Centene (搜索) posted net income of $1.09 billion, or $2.19 per share, in the second quarter of 2026, marking a sharp reversal from a loss of $253 million, or 50 cents per share, in the year-ago period. The St. Louis-based managed care organization handily beat Wall Street expectations, driven by higher premium revenue, improved pricing, and better management of medical costs across its commercial and government-sponsored health plans.
"Any way you slice it, this was a fantastic quarter," said CFO Drew Asher during a morning call with investors.
The results represent the second consecutive beat-and-raise quarter for Centene (搜索) this year, following a buoyant first quarter when the company bumped its 2026 guidance on the back of better-controlled medical costs.
Medical Cost Management Shows Progress
Centene (搜索)'s consolidated health benefits ratio (HBR) — the percentage of premium revenue spent on medical costs — fell to 89.6% for the second quarter, down from 93% in the same period last year. The improvement reflects a combination of factors, including lower marketplace HBR resulting from improved pricing and risk transfer reflecting the acuity of marketplace membership, as well as rate and revenue increases and continued progress in managing medical costs in the Medicaid business.
The commercial medical loss ratio (MLR) came in at 79.2%, a notable improvement from 90.6% a year earlier. The better MLR is attributable to Centene (搜索) raising ACA premiums for 2026 and a "tapering" medical trend that drove spending lower than anticipated, according to Asher.
"Our second quarter results and improved full-year outlook represent meaningful milestones on our path to restoring profitability and increasing shareholder value," said Centene (搜索) CEO Sarah M. London. "We are excited by the positive momentum we have built and remain focused on our goal of delivering industry-leading health outcomes with an industry-leading cost structure."
ACA Marketplace: Smaller but More Profitable
The biggest boost for Centene (搜索) came from the Affordable Care Act exchanges — a business that had been one of the largest drags on earnings. ACA marketplace enrollment dropped to approximately 3.5 million at the end of the second quarter, compared to 5.8 million a year earlier, a decline of nearly 2.4 million members.
The steep enrollment decline follows the expiration of enhanced federal subsidies for ACA plans after Republicans in Congress and the Trump administration declined to extend them. A KFF analysis had warned that middle-income Americans as well as those with low incomes would see major out-of-pocket premium increases without the enhanced tax credits.
Despite the membership losses, the remaining enrollees are significantly more profitable. Centene (搜索) also benefited from a higher payout from the risk adjustment program, which reimburses insurers that cover sicker enrollees. That risk adjustment settlement contributed approximately $180 million in net pre-tax favorability in the quarter and about $481 million in the first half of the year.
Centene (搜索) now expects its ACA business to yield a 4.5% to 5% margin in 2026, up from previous guidance and "back on track after a temporary industry detour in 2025," Asher said.
Medicaid and Medicare Performance
Centene (搜索)'s Medicaid business, which accounts for roughly half of total membership and premiums, posted an MLR of 93.9%, down from 94.9% in the prior-year period. The insurer lost more than 700,000 Medicaid members year over year, leaving it with 12.1 million enrollees. The step-down was larger than anticipated as states tweaked their Medicaid programs in ways that trimmed eligibility, London noted.
Centene (搜索)'s Medicare business also outperformed expectations, posting an MLR of 89.5%, down from 90.9% a year earlier. The company said margin improvement in its Medicare Advantage plans has accelerated after trimming the business for 2026, with further reductions planned for 2027.
Financial Outlook and Strategic Moves
Premium and service revenues rose 4% to $44.4 billion from $42.5 billion in the year-ago period, while total revenue reached $53.6 billion, up 10% year over year. Centene (搜索) raised its 2026 adjusted earnings per share guidance to greater than $4.80, up from $3.40 previously — a move TD Cowen analyst Ryan Langston called "huge."
The improved outlook remains well below the $7.17 and $6.68 in adjusted EPS that Centene (搜索) enjoyed in 2024 and 2023, respectively, before the company was hit with unexpected medical spending.
With falling membership driving higher margins, Centene (搜索) has also moved to downsize its workforce. The company began offering its 61,000 employees buyouts earlier this year. Second-quarter expenses included $37 million in "enterprise optimization" costs and another $15 million in severance spending.
On the governance front, Centene (搜索) announced that board member Kenneth Burdick, who has served since 2022, is retiring. He will be replaced by Paul Diaz, a managing partner at private equity and investment firm Cressey & Company and former CEO of Myriad Genetics and Kindred Healthcare.